Hemangiosarcoma…the old and the new

Webinar rating:
Published on: 19.07.2017


Shasta Lynch BVSc(hons) MANZCVS(SAM) DipECVIM-CA(Oncology) MRCVS Australian,
RCVS and European Veterinary Specialist in Oncology

Add to favorites

About The Webinar

Hemangiosarcoma is an aggressive tumour of vascular endothelial origin. In dogs it accounts for 45-51% of splenic tumours. The most common presentation is acute weakness or collapse and haemoabdomen. Treatment of canine splenic hemangiosarcoma involves a combination of surgery and chemotherapy in order to maximise survival times. In this webinar we discuss the diagnosis, clinical staging, treatment and prognosis for hemangiosarcoma of the spleen and other body locations in dogs and cats. We review traditional treatment options as well as discuss what's new in the medical treatment of hemangiosarcoma and what's likely around the corner for our veterinary patients.

CPD/CE Tracker

When you have watched the webinar, click on the 'Add To Tracker' button below. This will add a record to your CPD Tracker dashboard located in the main menu under 'My Membership'. Complete the reflective learning fields for future reference. When you click 'update' the information is saved. You can edit this information at a later date either on the webinar page or in your CPD Tracker dashboard. We recommend you download your record regularly for safekeeping.